D-0654-2024 Class II Ongoing
FDA drug recall D-0654-2024 was initiated by ProRx LLC on August 22, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 500 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- September 11, 2024
- Initiation Date
- August 22, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 500 vials
Product Description
Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide in the USA
Code Information
Lot # ProRx031924-1, BUD 09/18/2024